Persian  |  Ahvaz Jundishapur University of Medical Sciences
I forgot my password

Journals Office: 2nd floor, School of Medicine Ahvaz Jundishapur University of Medical Sciences, Golestan BLV, Ahvaz - IRAN
Postal Code: 6135715794
Phone: +98-61-33738283
Fax: +98-61-33362537

Home :: Back

Advance Article Search New

Jundishapur J Oncol;2015; March
Article title: Evaluation of correlation between the expression of p53 as a immunohistochemical marker&prognosis of gastric cancer

Article File:    Article (PDF) 1073 Kb 
Page From: 5 To: 7      
Visit: 1642

Introduction: Background: Gastric cancer is the most common form of gastro intestinal malignancy in certain part of the word and the most common type is Adenocarcinoma. The tumor suppressor gene p53 is a nuclear protein which plays a key role in tumor progression. Therefore in this study, we investigate p53 expression in gastric cancer specimens and possible relationship between this marker and clinical-pathological factors of disease. Material and methods: This study included 54 patients with primary Adenocarcinoma of stomach whom under-went gastrectomy at the Ahvazs Emam Khomeini hospital. Tumor specimens examined by immuno-histochemical staining with monoclonal antibody against p53. For evaluate value of p53, A stain was considered positive, when %20 of cancer cells showed a positive nuclear staining. Result: P53 marker was positive in 40 cases (%74) of all cases. Stronger expression of p53 was related with higher grade (p=0/035) and lymph node metastasis (p=0/033). No significant differences were seen between value of p53 marker with age, sex, tumor size, depth of invasion and tumor type. Expression of p53 was not correlate with vas-cular and neural invasion or involvement of margins. Conclusion: In gastric cancer, the expression of p53provides significant information about prognosis and evalua-tion of p53 level could be a useful tool in identification of patients with more aggressive disease.

p53, Adenocarcinoma, Immunohistochemical staining

Article Authors:
Nastaran RanjbariFirst
Neda HojatpanahFirst Author

1-Chakavarthi S, Seng Long A, Hannein B, Pasupati T. The expression of p53 as a reliable immune histochemical marke for clinicopathological correlation of gastricadeno carci- noma. Research Journal of Medical Sciences. 2010; (1) 15-19.
2-Seo YH, Joo YE, Choi SK, Rew JS, Park CS, Kim SJ. Prognostic significance of p21 and p53 expression in gastric cancer. korean j intern med. 2003; (2):98-103.
3-Schneider PM, Casson AG, Levin B, et al. Mutations of p53 in Barrett’s esophagus and Barrett’s cancer: a prospective study of ninety-eight cases. J Thorac Cardiovase Surg. 1996; 111:323–331.
4-Kim JH, Takahashi T, Chiba I, Park JG, Birrer MJ, Roh JK, De Lee H, Kim JP, Minna JD, Gazdar AF. Occurrence of p53 gene abnormalities in gastric carcinoma and cell lines. J Natl Cancer Inst. 1991; 83(13):938-43.
5-carnerio f l.david.oncogenes and oncosuppressor genes in gastric carcinoma.1994. Surg.Pathol 5(3):225-238.
6-Strazynska T, Bromery M, Ghosh A, Stern P. Prognostic significance of p53 overexpressionin gastric and colorectal carcinoma. Br J Cancer. 1992; (3):558-62.
7-Okuyama T, Maehara Y, Kabashima A, Takahashi I, Kakeji Y, Sugimachi K. combined evaluation of expression of p53and p21 as prognostic factors for patient with a gastric carcinoma. Oncology. 2002; :353-361.
8-Tzanakis NE, Peros G, Karakitsos P, Giannopoulos GA, Ef- stathiou SP, Rallis G, Tsigris C, Kostakis A, Nikiteas NI. Prognostic significans of p53 and Ki 67 proteins expression in greek gastric cancer patient. Acta Chir Belg. 2009; 109(5):606-11
9-Muller w, Bochard F. Prognostic influence of p53 expression in gastric cancer. J Pathol. 1997; (3):255-8.
10-Yonemura y, fushida a, tsugawa K, ninomiya L, fonseca L, et al. correlation of p53 expression and proliferative activity in gastric cancer. Anal cell pathol. 1993; :277- 288.
11-Shiroko T, Saji S, Kawaguchi Y, Kageyama T, Kunieda K, Umemoto T. A study on the relationship between clinico pathological findings of gastric cancer and its biological behavior such as DNA ploidy pattern and immunohistochemical staining of PCNA, laminin, p53 and nm 23. Gan To Kagaku Ryoho. 1995; 22Suppl 2:118- 23.
12-Pinto-de-Sousa J, Silva F, David L, Leitão D, Seixas M, Pimenta A, Cardoso-de-Oliveira M. Clinicopathological sig- nificance and survival influence of p53 protein expression in gastric carcinoma. Histopathology. 2004; 44(4):323-31
13-Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol. 2003; 33(4):173-9.
14-Lazăr D, Tăban S, Sporea I, Dema A, Cornianu M, Lazăr E, Goldiş A, Raţiu I, Vernic C. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients. Rom. J Morphol Embryol. 2010; 51(2):249-57.

کلیه حقوق این سایت متعلق به دانشگاه علوم پزشکی جندی شاپور اهواز می باشد. استفاده از مطالب این سایت با ذکر نام سایت مجاز می باشد   -   Copyright © 2012
Powered By
تولید کننده سیستم های تخصصی مدیریت نشریات و همایش ها و مورد تائید وزارت بهداشت درمان و آموزش پزشکی و وزارت ارتباطات و فناوری اطلاعات و